Matt, Author at European Medical Journal - Page 46 of 212

Optimisation of a Native Cardiac Scan Protocol in the Post-Mortem CT

CT has become an established practise in forensic imaging, in which this method is called post-mortem CT…

Mental Health and Wellness Education for Medical Radiation Technologists: Workplace Implications and Attitudes

The Mental Health Commission of Canada reports healthcare workers are 1.5 times more likely to be absent from work than other sectors, with mental illness being the leading cause of disability…

ESR Annual Meeting 2020 Interview: Prof Nandita deSouza

Prof Nandita deSouza | Chairperson of the European Imaging Biomarkers Alliance – EIBALL. Institute of Cancer Research (ICR), London, UK…

18F-FET or 18F-FCH PET/CT in the Primary Diagnosis of Low-Grade Glioma: A Pilot Study

Gliomas are associated with variable survival, linked to their histological type…

Cardiology CP

High Prevalence of Metabolic Factors in Both Young and Old Patients with Acute Coronary Syndrome - Interim Results of Metabolic Risk Factors in First ACS Study (Merifacs)

Prevalence of coronary artery disease in developing countries is increasing…

Cardiology CP

Progression of Valvular Calcification is Associated with 10-Year Change in Left Ventricular Structure and Incident Heart Failure: MESA

Heart failure (HF) is a leading cause of morbidity…

Cardiology CP

Profiling the Discordant Visceral Adipose Tissue–Ectopic Liver Fat Phenotype: Results from the Dallas Heart Study

The accumulation of visceral adipose tissue (VAT) and ectopic liver fat (ELF) generally parallel each other, but a proportion of individuals have discordant fat deposition…

EMJ Oncology 8 [Supplement 2] 2020

Review of the Latest Developments in Treatment of Hormone Receptor-Positive Advanced Breast Cancer

MONARCH 2 was a global, randomised, double-blind, Phase III study of abemaciclib or placebo in combination with fulvestrant in premenopausal…

EMJ Oncology 8 [Supplement 2] 2020

Latest Developments in Advanced Breast Cancer Treatment: A Discussion with Two Key Opinion Leaders about the CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib

The introduction of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in the treatment of advanced breast cancer (ABC; inoperable locally advanced…

Interview: Prof Andrew Shennan

Prof Andrew Shennan | Professor of Obstetrics, King’s College London, St Thomas’ Hospital, London, UK…